Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cipta Sarana Medika Tbk. (DKHH) vs Prodia Diagnostic Line Tbk (PRDL) Price & Performance

Cipta Sarana Medika Tbk.Trade
Prodia Diagnostic Line TbkTrade

Price performance (Past 24H)

Key statistics

Cipta Sarana Medika Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Prodia Diagnostic Line Tbk is far larger — about 2.9× Cipta Sarana Medika Tbk.'s market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 14.05M). Which is the better fit depends on your goals.

DKHHPRDL
Market Cap
160.67B470.58B
Volume
14.05M28.43M
Lot
140.49K284.34K
Turnover
899.67M7.8B
Average Price
64.04274.19
Value
899.67M7.8B
Indicative Equilibrium Price
64270
Indicative Equilibrium Volume
1002.1K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKHH
View details
PRDL
View details

About Cipta Sarana Medika Tbk.

PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.

Read more on DKHH

About Prodia Diagnostic Line Tbk

PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.

Read more on PRDL